GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4982)

  • GC71128 structure
    GC71128Diclofenac-d4 sodium
    CAS: 154523-54-3
    Purity: >99.00%

    Diclofenac-d4 sodium ist das Deuterium markierte Diclofenac-Natrium.

  • GC71144 structure
    GC71144Phytoene desaturase-IN-1
    CAS: 2765793-54-0
    Purity: >99.00%

    Phytoene desaturase-IN-1 ist ein potenter Phytoendesaturase (PDS)-Inhibitor (Kd: 65,9 μM) durch π−π Stapelwirkung mit Phe301-Rückständen.

  • GC71149 structure
    GC71149NIC-0102
    CAS: 2806031-94-5
    Purity: >98.00%

    NIC-0102 ist ein oral aktiver Proteasom-Inhibitor (pIC50=7,55), der speziell die Aktivierung der entzündlichen NLRP3-Vesikel hemmt.

  • GC71181 structure
    GC71181Glucocorticoid receptor modulator 1
    CAS: 2868357-11-1
    Purity: >99.00%

    Glucocorticoid receptor modulator 1 is a highly potent and orally active non-steroidal selective glucocorticoid receptor modulator with an IC50 value of 9 nM and 130 nM for NF-κB and AP-1, respectively.

  • GC71186 structure
    GC71186STING-IN-4
    CAS: 2250374-27-5
    Purity: >99.00%

    STING-IN-4 (Verbindung 1) ist ein STING-Inhibitor, der die STING-Expression hemmt und somit die Aktivierung des STING- und nuklearen Faktor-κB-Signals (NF-κB) reduziert.

  • GC71189 structure
    GC71189STING-IN-5
    CAS: 2920064-17-9

    STING-IN-5 ist ein potenter STING-Inhibitor, der die LPS-induzierte NO-Synthese in Makrophagen mit einem IC50-Wert von 1,15 μM hemmt.

  • GC71230 structure
    GC71230NLRP3-IN-17
    CAS: 2254432-75-0
    Purity: >99.00%

    NLRP3-IN-17 ist ein potenter, selektiver und oral aktiver NLRP3-Entzündungshemmer mit einem IC50-Wert von 7 nM.

  • GC71232 structure
    GC71232I-152
    CAS: 311343-11-0
    Purity: >98.00%

    I-152 ist ein Konjugat, das N-Acetylcystein (NAC) und Cysteamin (MEA) enthält.

  • GC71258 structure
    GC71258ASK1-IN-4
    CAS: 1427538-26-8

    ASK1-IN-4 (Verbindung 17) ist ein ASK1-Hemmer (IC50=0,2 μM).

  • GC71259 structure
    GC71259NH2-C6-ARC186 sodium
    Purity: >92.00%

    NH2-C6-ARC186 sodium ist ein modifiziertes ARC186 mit NH2-C6, das mit anderen Peptiden oder Molekülen gekoppelt werden kann.

  • GC71273 structure
    GC71273C12-TLRa
    Purity: >99.00%

    C12-TLRa ist ein adjuvantes Lipidoid.

  • GC71351 structure
    GC71351HMGB1-IN-1
    Purity: >95.00%

    HMGB1-IN-1 (Verbindung 6) zeigt eine starke NO-hemmende Wirkung in RAW264.7 Zellen mit IC50 Wert von 15,9 ± 0,6 μM.

  • GC71352 structure
    GC71352Anti-inflammatory agent 51
    CAS: 2911610-03-0
    Purity: >98.00%

    Anti-inflammatory agent 51 (Verbindung 11d) ist ein Amid/Sulfonamid-Derivat mit entzündungshemmender Wirkung.

  • GC71353 structure
    GC71353VU534
    CAS: 923509-20-0
    Purity: >98.00%

    VU534 ist ein NAPE-PLD-Aktivator mit einem EC50 von 0,30 μM.

  • GC71384 structure
    GC71384ALPK1-IN-3
    CAS: 2765633-73-4
    Purity: >98.00%

    ALPK1-IN-3 ist ein Inhibitor von ALPK1, extrahiert aus dem Patent WO2022063153A1 Verbindung T007.

  • GC71396 structure
    GC71396Usnoflast
    CAS: 2455519-86-3
    Purity: >98.00%

    Usnoflast ist ein NLRP3-Modulator sowie ein nichtsteroidales entzündungshemmendes Mittel (NSAD).

  • GC71405 structure
    GC71405ADS032
    CAS: 2757333-37-0
    Purity: >99.50%

    ADS032 ist ein dualer Inhibitor von NLRP1 und NLRP3, der die Bildung von Entzündungen schnell, reversibel und stabil hemmen kann.

  • GC71433 structure
    GC71433Anti-inflammatory agent 70
    Purity: 97.00%

    Anti-inflammatory agent 70 (N-Me-SP23) ist ein STING Proteinabbau und hemmt den STING Signalweg.

  • GC71470 structure
    GC71470cGAS-IN-2
    CAS: 2765273-11-6

    cGAS-IN-2 (Verbindung 109) ist ein starker Hemmer der zyklischen GMP-AMP Synthase (cGAS), mit IC50 von 0,01512 μM für h-cGAS.

  • GC71474 structure
    GC71474NSC80734
    CAS: 501950-47-6

    NSC80734 ist ein IL-18-Hemmer.

  • GC71480 structure
    GC71480Drpitor1a
    CAS: 73326-98-4
    Purity: >96.50%

    Drpitor1a ist ein starker Drp1-Hemmer.

  • GC71499 structure
    GC71499NP3-562
    CAS: 2409825-32-5

    NP3-562 ist ein potenter, oral aktiver, trizyklischer NLRP3-Inhibitor mit einem IC50 von 214 nM.

  • GC71507 structure
    GC715075'-Methylthioadenosine-13C6
    CAS: 2421187-73-5

    5'-Methylthioadenosine-13C6 ist das 13C-markierte 5'-Methylthiodenosin.

  • GC71544 structure
    GC71544Antroquinonol
    CAS: 1010081-09-0
    Purity: >98.00%

    Antroquinonol(+)-Antroquinonol), ein Ubiquinon-Derivat aus dem Pilz Antrodia camphorata, wirkt hepatoprotektiv, entzündungshemmend und krebshemmend.